Skip to main content
Log in

Whole-Transcriptome Analysis of Serum L1CAM-Captured Extracellular Vesicles Reveals Neural and Glycosylation Changes in Autism Spectrum Disorder

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The pathophysiology of autistic spectrum disorder (ASD) is not fully understood and there are no diagnostic or predictive biomarkers. Extracellular vesicles (EVs) are cell-derived nano-sized vesicles, carrying nucleic acids, proteins, lipids, and other bioactive substances. As reported, serum neural cell adhesion molecule L1 (L1CAM)-captured EVs (LCEVs) can provide reliable biomarkers for neurological diseases; however, little is known about the LCEVs in children with ASD. The study enrolled 100 children with ASD (2.5–6 years of age; 90 males) and 60 age-matched TD children (54 males) as control. The serum sample was collected and pooled into five ASD subgroups and three TD subgroups (n = 20). LCEVs were isolated and characterized meticulously. Whole-transcriptome of LCEVs was analyzed by lncRNA microarray and RNA-sequencing. All raw data was submitted on GEO Profiles, and GEO accession numbers is GSE186493. RNAs expressed differently in LCEVs from ASD sera vs. TD sera were screened, analyzed, and further validated. A total of 1418 mRNAs, 1745 lncRNAs, and 11 miRNAs were differentially expressed, and most of them were downregulated in ASD. Most RNAs were involved in neuron- and glycan-related networks implicated in ASD. The levels of EDNRA, SLC17A6, HTR3A, OSTC, TMEM165, PC-5p-139289_26, and hsa-miR-193a-5p were validated in at least 15 ASD and 15 TD individual serum samples, which were consistent with the results of transcriptome analysis. In conclusion, whole-transcriptome analysis of serum LCEVs reveals neural and glycosylation changes in ASD, which may help detect predictive biomarkers and molecular mechanisms of ASD, and provide reference for diagnoses and therapeutic management of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ASD:

Autism spectrum disorder

EVs:

Extracellular vesicles

L1CAM:

Neural cell adhesion molecule L1

LCEVs:

L1CAM-captured extracellular vesicles

TD:

Typically developed

DSM:

Diagnostic and Statistical Manual of Mental Disorders

APOD:

Apolipoprotein D

DBS − 2:

Dulbecco’s balanced salt solution

SDS:

Sodium dodecyl sulfonate

qRT-PCR:

Quantitative real-time PCR

HCA:

Hierarchical clustering analysis

PCA:

Principal component analysis

DEmRs:

Differentially expressed mRNAs

DElnRs:

Differentially expressed lncRNAs

DEmiRs:

Differentially expressed miRNAs

HTR3A:

5-Hydroxytryptamine receptor 3A

SERT:

Serotonin transporter

SLC17A6:

Vesicular glutamate transporter 2

Glu:

Glutamate

ECM:

Extracellular matrix

CDGs:

Congenital glycosylation disorders

OST:

Oligosaccharyl transferase

References

Download references

Acknowledgements

The authors sincerely thank all the participants.

Funding

This work was supported by the National Natural Science Foundation of China(No. 81401137 and No. 81972603), and the Natural Science Foundation of Shaanxi Province (No.2017JM8112).

Author information

Authors and Affiliations

Authors

Contributions

Y.Q. carried out analysis of data from lncRNA microarray and RNA sequencing, generated the graphs, and wrote the manuscript; L.C. took charge of preparation of serum samples, isolation and characterization of serum LCEVs, and qRT-PCR; J.Z. took on the data analysis, graphing, and manuscript revision; H.Z. collected samples from patients and summarize the clinical information of patients; S.C. and L.Z. participated in data analysis; B.G. performed extraction of LCEVs; F.W., W.L., and X.W. participated in bioinformatics analysis; L.N. and L.L. modified the draft of this paper; Y.C. performed ASD diagnosis and sample collection; and C.H. participated in the design of the project, coordination of the staff, and revision of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yanni Chen or Chen Huang.

Ethics declarations

Ethics Approval and Consent to Participate

The Ethics Committee of Xi’an Jiaotong University (Xi’an, China) provided institutional ethical approval for this study.

Consent for Publication

All parents of the participants signed written informed consent.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 7991 KB)

Supplementary file2 (XLSX 1459 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qin, Y., Cao, L., Zhang, J. et al. Whole-Transcriptome Analysis of Serum L1CAM-Captured Extracellular Vesicles Reveals Neural and Glycosylation Changes in Autism Spectrum Disorder. J Mol Neurosci 72, 1274–1292 (2022). https://doi.org/10.1007/s12031-022-01994-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-022-01994-z

Keywords

Navigation